The Short Cosyntropin Test Revisited: New Normal Reference Range Using LC-MS/MS
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background: The cosyntropin test is used to diagnose adrenal insufficiency (AI) and nonclassical congenital adrenal hyperplasia (NCCAH). Current cutoffs for cortisol and 17-hydroxyprogesterone (17-OHP) are derived from nonstandardized immunoassays. Liquid chromatography tandem mass spectrometry (LC-MS/MS) offers direct measurement of steroids, prompting the need to re-establish normal ranges. Objective: The goal of this study was to define cutoff values for cortisol and 17-OHP in serum by LC-MS/MS 30 and 60 minutes after intravenous administration of 250 µg tetracosactide acetate to healthy volunteers and to compare the results with LC-MS/MS with routine immunoassays. Methods: Cosyntropin testing was performed in healthy subjects (n = 138) and in patients referred for evaluation of adrenocortical function (n = 94). Steroids were assayed by LC-MS/MS and compared with two immunoassays used in routine diagnostics (Immulite and Roche platforms). The cutoff level for cortisol was defined as the 2.5% percentile in healthy subjects not using oral estrogens (n = 121) and for 17-OHP as the 97.5% percentile. Results: Cortisol cutoff levels for LC-MS/MS were 412 and 485 nmol/L at 30 and 60 minutes, respectively. Applying the new cutoffs, 13 of 60 (22%) subjects who had AI according to conventional criteria now had a normal test result. For 17-OHP, the cutoff levels were 8.9 and 9.0 nmol/L at 30 and 60 minutes, respectively. Conclusions: LC-MS/MS provides cutoff levels for cortisol and 17-OHP after cosyntropin stimulation that are lower than those based on immunoassays, possibly because cross-reactivity between steroid intermediates and cortisol is eliminated. This reduces the number of false-positive tests for AI and false-negative tests for NCCAH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Serum cortisol concentrations are approximately 20% lower with the newer assays compared with the older assays in some studies [8, 13, 15, 26, 27].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [26]
In the citing paper
“Newer, more-specific cortisol assays with lower cross-reactivity to other endogenous steroids have replaced older, less-specific assays [8, 13, 15, 26, 27].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [26]
In the citing paper
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [26]
In the citing paper
“Cutoff values 30 minutes after ACTH stimulation have been proposed to be 14.9 μg/dL for LC-MS/MS and 16 μg/dL for Elecsys II based on the 2.5th centile in healthy controls [26].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [26]
In the citing paper
“Despite that, previous studies in healthy subjects using more-specific cortisol assays including LC-MS/MS have found a lower peak cortisol response to ACTH stimulation that was very similar to the lower cortisol threshold reported in our study [10, 26].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [26]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,575
Kirschbaum, C., Kudielka, B. M., Gaab, J., Schommer, N. C., & Hellhammer, D. H. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199903000-00006 · Cited by 1,890
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
Self-citationRosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Rao, K. J. P. H., Janardhan, K., & Rao, P. (2010) · Cited by 559
Influence of Statistical Method Used on the Resulting Estimate of Normal Range
Reed, A. H., Henry, R. J., & Mason, W. B. (1971) · Clinical Chemistry · doi:10.1093/clinchem/17.4.275 · Cited by 531
Congenital Adrenal Hyperplasia: Is there an Effect on Penile Growth?
Levy, J. B., & Husmann, D. A. (1996) · The Journal of Urology · doi:10.1097/00005392-199608001-00060 · Cited by 415
Husebye, E. S., Allolio, B., Arlt, W., Badenhoop, K., Bensing, S., Betterle, C., Falorni, A., Gan, E. H., Hulting, A. ‐., Kasperlik‐Zaluska, A., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12162 · Cited by 403
Self-citationWright, A., & Coombes, A. E. R. (1948) · The Lancet · doi:10.1016/s0140-6736(48)91204-5 · Cited by 346
Cited by
Husebye, E. S., Pearce, S. H., Krone, N. P., & Kämpe, O. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00136-7 · Cited by 378
Self-citationHahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Self-citationHusebye, E. S., Castinetti, F., Criseno, S., Curigliano, G., Decallonne, B., Fleseriu, M., Higham, C. E., Lupi, I., Paschou, S. A., Toth, M., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0689 · Cited by 192
Self-citationJavorsky, B. R., Raff, H., Carroll, T. B., Algeciras-Schimnich, A., Singh, R. J., Colón-Franco, J. M., & Findling, J. W. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab022 · Cited by 171
“Despite that, previous studies in healthy subjects using more-specific cortisol assays including LC-MS/MS have found a lower peak cortisol response to ACTH stimulation that was very similar to the lower cortisol threshold reported in our study [10, 26].”
BackgroundMethodResultInfluentialAn Update on Addison’s Disease
Barthel, A., Benker, G., Berens, K., Diederich, S., Manfras, B. J., Grüber, M., Kanczkowski, W., Kline, G. A., Kamvissi, V., Hahner, S., et al. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0804-2715 · Cited by 135
The changing face of adrenoleukodystrophy
Zhu, J., Eichler, F., Biffi, A., Duncan, C. N., Williams, D. A., & Majzoub, J. A. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa013 · Cited by 78
Investigation of the Hypothalamo-pituitary-adrenal (HPA) axis: a contemporary synthesis
Karaca, Z., Grossman, A. B., & Keleştimur, F. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09611-3 · Cited by 83
“Immunological tests including Immulite and Roche platforms were found to have similar results to LC-MS/MS despite higher median cortisol levels [15].”
ResultKumar, R., & Wassif, W. (2022) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2021-207895 · Cited by 69
Adrenal Venous Sampling for Assessment of Autonomous Cortisol Secretion
Ueland, G. Å., Methlie, P., Jøssang, D. E., Sagen, J. V., Viste, K., Thordarson, H. B., Heie, A., Grytaas, M. A., Løvås, K., Biermann, M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01198 · Cited by 54
Self-citationGrassi, G., Morelli, V., Ceriotti, F., Polledri, E., Fustinoni, S., D’Agostino, S., Mantovani, G., Chiodini, I., & Arosio, M. (2020) · Hormones · doi:10.1007/s42000-020-00185-y · Cited by 46
Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
Adriaansen, B. P. H., Schröder, M. A. M., Span, P. N., Sweep, F. C. G. J., van Herwaarden, A. E., & der Grinten, H. L. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1064024 · Cited by 51
Approach to the Patient With Glucocorticoid-induced Adrenal Insufficiency
Borresen, S. W., Klose, M., Glintborg, D., Watt, T., Andersen, M., & Feldt‐Rasmussen, U. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac151 · Cited by 47
Uslar, T., Olmos, R. I., Martínez‐Aguayo, A., & Baudrand, R. F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093128 · Cited by 49
“International guidelines recommend LC-MS/MS given its specificity and accuracy [6,9,10].”
BackgroundZha, L., Li, J., Krishnan, S. M., Brennan, M. R., Zhang, Y. V., Povse, P., Kerlin, R., Shively, K., Oleksik, F., Williams, J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.04.003 · Cited by 34
Laugesen, K., Broersen, L. H. A., Hansen, S. B., Dekkers, O. M., Sørensen, H. T., & Jorgensen, J. O. L. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1199 · Cited by 32
Perioperative evaluation and management of patients on glucocorticoids
Chen Cardenas, S. M., Santhanam, P., Morris-Wiseman, L., Salvatori, R., & Hamrahian, A. H. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac185 · Cited by 31
Borresen, S. W., Thorgrimsen, T. B., Jensen, B., Hilsted, L., Bartels, E. M., Feldt‐Rasmussen, U., & Locht, H. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa011 · Cited by 31
Dichtel, L. E., Haines, M. S., de Assis, C. L., Rao, E. M., Sims, J. K., Corey, K. E., Kohli, P., Sluss, P. M., McPhaul, M. J., & Miller, K. K. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00022 · Cited by 32
Residual Corticosteroid Production in Autoimmune Addison Disease
Sævik, Å. B., Åkerman, A., Methlie, P., Quinkler, M. O., Jørgensen, A. P., Höybye, C., Dębowska, A., Nedrebø, B. G., Dahle, A. L., Carlsen, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa256 · Cited by 31
“A normal response was defined as peak cortisol exceeding 412 or 485 nmol/L after 30 or 60 minutes, respectively (9).”
Self-citationHusni, H., Abusamaan, M. S., Dinparastisaleh, R., Sokoll, L., Salvatori, R., & Hamrahian, A. H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.978238 · Cited by 26
Opioids and pituitary function: expert opinion
Gadelha, M. R., Karavitaki, N., Fudin, J., Bettinger, J. J., Raff, H., & Ben-Shlomo, A. (2022) · Pituitary · doi:10.1007/s11102-021-01202-y · Cited by 27
“As ACTH1–24-stimulation test cutoffs have not been systematically validated in patients treated chronically with opioids, we recommend that the criteria for serum cortisol thresholds after ACTH1–24 stimulation should follow the established cutoffs of 14–15 μg/ dL (386–413 nmol/L) with mass spectrometry and secondgener…”
BackgroundOkutan, S., Jørgensen, N. T., Pedersen, L. E., Borresen, S. W., Hilsted, L. M., Friis-Hansen, L. J., Feldt‐Rasmussen, U., & Klose, M. (2024) · Endocrine · doi:10.1007/s12020-024-03752-0 · Cited by 28
“The high concordance with the gold standard method LC-MS/MS measuring baseline and stimulated cortisol concentrations was also reported by others [14, 18, 20] and underlines that with ElecsysCort II we now have an immunoassay that produces more reliable results for the establishment of a cortisol…”
InfluentialLatent Adrenal Insufficiency: From Concept to Diagnosis
Younès, N., Bourdeau, I., & Lacroix, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.720769 · Cited by 27
Ueland, G. Å., Dahl, S. R., Methlie, P., Hessen, S., Husebye, E. S., & Thorsby, P. M. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.05.012 · Cited by 24
Self-citationBurgos, N., Ghayee, H. K., & Singh-Ospina, N. (2019) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000473 · Cited by 23
Adrenal Failure: An Evidence-Based Diagnostic Approach
Shaikh, S., Nagendra, L., Shaikh, S. S., & Pappachan, J. M. (2023) · Diagnostics · doi:10.3390/diagnostics13101812 · Cited by 23
“However, we have to bear in mind that when using newer highly specific cortisol assays such as liquid chromatography–tandem mass spectrometry (LC–MS/MS), the cut-off values can be lower at 412 and 485 nmol/L at 30 and 60 min (of stress testing), respectively, as shown by the newer studies [30].”
MethodACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow
Birtolo, M. F., Antonini, S., Saladino, A., Zampetti, B., Lavezzi, E., Chiodini, I., Mazziotti, G., Lania, A. G. A., & Cozzi, R. (2023) · Biomedicines · doi:10.3390/biomedicines11030904 · Cited by 19
Pre-test cortisol levels in predicting short synacthen test outcome: a retrospective analysis
Ravindran, R., Carter, J. L., Kumar, A., Capatana, F., Khan, I. N., Adlan, M. A., & Premawardhana, L. D. (2022) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514221093316 · Cited by 17
“While most studies report no influence of the timing of testing on SST outcome, 3,19,20 1 study reported a higher failure rate in the afternoon.”
Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults
Øksnes, M., & Husebye, E. S. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad402 · Cited by 21
Self-citationChesover, A., Millar, H., Sepiashvili, L., Adeli, K., Palmert, M. R., & Hamilton, J. K. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz030 · Cited by 15
“Re-evaluating the cortisol threshold for diagnosing primary adrenal insufficiency (from any cause) is outside the scope of this study; but this work should be undertaken to better identify individuals with NCCAH who may be at risk of adrenal insufficiency [11, 12, 26].”
Utility of Salivary Cortisol and Cortisone in the Diagnostics of Adrenal Insufficiency
Hellan, K. K., Lyngstad, M., Methlie, P., Løvås, K., Husebye, E. S., & Ueland, G. Å. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae486 · Cited by 13
Self-citationChanges in Adrenal Function and Insufficiency Symptoms After Cessation of Prednisolone
Hansen, S. B., Dreyer, A. F., Jørgensen, N. T., Al-Jorani, H., Bislev, L. S., Boesen, V. B., Borresen, S. W., Christensen, L. L., Glintborg, D., Hauge, E., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.1029 · Cited by 14
Besemer, F., Kramers, C., Brinkman, K., Hermus, A. R., van Herwaarden, A. E., & Burger, D. M. (2020) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-020-00995-5 · Cited by 10
Feldt‐Rasmussen, U., & Klose, M. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102020 · Cited by 9
Sævik, Å. B., Ueland, G. Å., Åkerman, A., Methlie, P., Quinkler, M. O., Jørgensen, A. P., Höybye, C., Dębowska, A., Nedrebø, B. G., Dahle, A. L., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad136 · Cited by 9
Self-citationInvestigating cortisol excess or deficiency: a practical approach
Hanna, F., Issa, B. G., Kevil, B., & Fryer, A. A. (2019) · BMJ · doi:10.1136/bmj.l6039 · Cited by 11
Do we need 30 min cortisol measurement in the short synacthen test: a retrospective study
Kumar, R., Carr, P., Moore, K., Rajput, Z., Ward, L., & Wassif, W. S. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2019-137125 · Cited by 8
Diagnostic strategies in adrenal insufficiency
Siampanopoulou, V., Tasouli, E., & Angelousi, A. G. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000806 · Cited by 9
Costa‐Barbosa, F. A., Carvalho, V. M., de Oliveira, K. C., Vieira, J. G. H., & Kater, C. E. (2021) · Clinical Endocrinology · doi:10.1111/cen.14550 · Cited by 7
“1%; subjects #1 and #2, mentioned above) had levels below 18 μg/dl, the conventional lowest normal F response to ACTH.(24,25) Of interest, three of 19 WT (15.”
BackgroundInfluentialDiagnosis and management of secondary adrenal crisis
Martel‐Duguech, L., Poirier, J., Bourdeau, I., & Lacroix, A. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09877-x · Cited by 7
“…newer immunoassay generations using antibodies with improved specificity, or liquid chromatography coupled with tandem mass spectroscopy (LC-MS/MS) lower cut-off limit has been recently defined as ACTH-stimulated 30-min cortisol readings in the range of 13,5 to 16 μg/dL (420–450 nmol/L [133–136].”
Bizzarri, C., Chioma, L., Bottaro, G., Paone, L., Todisco, T., Chiarito, M., Surace, C., Porzio, O., D’Alessandro, A., Ravà, L., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02581-w · Cited by 7
A practical approach to diagnosis and treatment in children with primary adrenal insufficiency
Capalbo, D., Illiano, S., Vasaturo, S., Lorello, P., Rotondo, F. R., Mase, R. D., Bizzarri, C., & Salerno, M. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf229 · Cited by 5
Birtolo, M. F., Giannini, E., Antonini, S., Lavezzi, E., Lasio, G. B., Rin, G. D., Mazziotti, G., & Lania, A. G. (2024) · Pituitary · doi:10.1007/s11102-023-01368-7 · Cited by 6
“Serum cortisol concentrations measured with the more specific assays when compared to those measured with the older ones are sharply lower by 20 up to 36%, according to different studies [28–30].”
EndoCompass project: endocrine laboratory medicine
Heijboer, A. C., Hillebrand, J. J., Keevil, B. G., Ladang, A., Davies, E., Mertens, J., Özben, T., Stankovic, S. D., van Herwaarden, A. E., & Raverot, V. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf036 · Cited by 3
Yeşildal, F., Serdar, M. A., & Özgürtaş, T. (2018) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2018-0214 · Cited by 3
“Several studies have been conducted to reevaluate these ranges according to LC-MS/MS based methods [19, 20].”
BackgroundImpact of systemic treatments for advanced thyroid cancer on the adrenal cortex
Colombo, C., Ceruti, D., Succi, M., Leo, S. D., Trevisan, M., Moneta, C., & Fugazzola, L. (2022) · European Thyroid Journal · doi:10.1530/etj-23-0246 · Cited by 3
“Nevertheless, since cortisol assays have recently become more sensitive and a new cutoff of 15 μg/dL has been proposed (23 , 24 , 25 ), we calculated the prevalence of PAI accordingly.”
MethodTosun, B. G., Turan, S., Haklar, G., Bereket, A., & Güran, T. (2025) · Hormone Research in Paediatrics · doi:10.1159/000544945 · Cited by 2
Repeated short corticotropin testing in patients with polymyalgia rheumatica
Gaster, T., Nielsen, A., Hansen, S. B., Donskov, A. O., Nielsen, M. K., Hansen, I. T., Nielsen, B. D., Kjær, S. G., Blegvad‐Nissen, J., Sørensen, C. M., et al. (2025) · Rheumatology · doi:10.1093/rheumatology/keaf614 · Cited by 2
EndoCompass Project: Endocrine Laboratory Medicine
Heijboer, A. C., Hillebrand, J. J., Keevil, B. G., Ladang, A., Davies, E., Mertens, J., Özben, T., Stankovic, S. D., van Herwaarden, A. E., & Raverot, V. (2025) · Hormone Research in Paediatrics · doi:10.1159/000549097 · Cited by 2
“…are repeated, Future research strategies should focus on improving the quality of dynamic testing and the interchangeability of test results by aligning procedures at the pre-analytical level, at the analytical level, and finally at the post-analytical level (i.e., redefined RIs or CDLs) [39, 40].”
Iliopoulos, G., & Daoussis, D. (2023) · Central Asian Journal of Medical Hypotheses and Ethics · doi:10.47316/cajmhe.2022.3.4.01 · Cited by 2
Okutan, S., Borresen, S. W., Hilsted, L. M., Feldt‐Rasmussen, U., & Klose, M. (2025) · Pituitary · doi:10.1007/s11102-025-01608-y · Cited by 1
Gasco, V., Bioletto, F., Lucisano, D., Camoirano, D., Cuboni, D., Varaldo, E., Sibilla, M., Aversa, L. S., Mocellini, F., Berton, A. M., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02807-5 · Cited by 1
Fernández-Velasco, P., Asensio, L. E., Torres, B., Buigues, A. O., Hoyos, E. G., García, E. D., Román, D. A. D. L., & Díaz-Soto, G. (2026) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2025.501685 · Cited by 1
Hillebrand, J. J., Bons, J. A. P., van den Berg, S. A. A., Heijboer, A. C., & van Herwaarden, A. E. (2026) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2026-0136 · Cited by 1
“We observed high agreement and correlations with minor bias for the Roche immunoassay compared to IHD LC-MS/MS, which was also shown before [2, 3, 16, 17].”
Araya, A. V., Pineda, P., Cordero, F., Ávila, D., & González, J. (2025) · Revista médica de Chile · doi:10.4067/s0034-98872025000300162 · Cited by 1
Øksnes, M., & Husebye, E. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00220-x · Cited by 1
Self-citationGubbi, S., Cordes, L. M., Kłubo-Gwieździńska, J., Madan, R. A., Nieman, L. K., Gulley, J. L., & Rivero, J. D. (2020) · The Oncologist · doi:10.1002/onco.13589
Diagnostic Challenges in Nonclassical Congenital Adrenal Hyperplasia
Escobar-Morreale, H. F., & Luque‐Ramírez, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_4
Adrenal insufficiency: a commentary
Ryan, A., & Twomey, P. J. (2022) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2022-208162
Nonclassic paradigm shift: Does anyone care?
Hurst, B. S. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.06.002
Confirmatory tests in steroid endocrinology
Honour, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818124-9.00006-1 · Cited by 1
Evidence-Based Neonatology: Neonatal Pituitary Hormone Deficiencies
Choleva, L., Yau, M., & Romero, C. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-69415-5.00025-4
Disorders of the Adrenal Gland in Children and Adolescents
Katugampola, H., & Krone, N. P. (2023) · Endocrinology · doi:10.1007/978-3-030-18901-3_4-1
Disorders of the Adrenal Gland in Children and Adolescents
Katugampola, H., & Krone, N. P. (2024) · Endocrinology · doi:10.1007/978-3-030-23709-7_4
Vibhatavata, P., Santiwanit, K., & Charatcharoenwitthaya, N. (2025) · Asian Medical Journal and Alternative Medicine · doi:10.70933/2773-9465.1002
Praktisches Management des Adrenogenitalen Syndroms
Wörther, H. (2025) · Journal für Endokrinologie Diabetologie und Stoffwechsel · doi:10.1007/s41969-025-00269-3
Adrenal Insufficiency in ASEAN: Barriers and Variations in Diagnosis and ManagementPreprint
Ramadoss, V., Cheong, L., Tan, L. K., Lazarus, K., Limumpornpetch, P., Puar, T. H. K., & Eng, P. C. (2025) · Research Square · doi:10.21203/rs.3.rs-7575544/v1
Kanazawa, K., Hijikata, M., & Kuwabara, K. (2025) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2025.10.010
“3,4,14,21-23 To classify AI severity, we continually evaluated the pituitary-adrenal axis by analyzing the differences in responses to SDST and LDST.”
Fernández-Velasco, P., Asensio, L., Torres, B., Buigues, A. O., Hoyos, E. G., García, E. D., Román, D. D. L., & Díaz-Soto, G. (2025) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2025.501685
Lefèvre, C. R., Vaduva, P., Kvasnička, A., Lenski, M., Senarathne, U. D., Taie, S. F., Zibar, K., & Rolić, T. (2026) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2026-0101
“For example, the post-cosyntropin cuto ff levels for cortisol and 17-hydroxyprogesterone in the diagnosis of adrenal insu ffi ciency are lower when assessed by LC-MS/MS than with immunoassays [47].”
Shrestha, E., Albert, S. G., Ghimire, A., Canales, S. P., Iqbal, I., & Akande, R. O. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.03.001
Cortisol Cutoffs for Adrenal Insufficiency Using Elecsys II: A Systematic Review
Haunton, S., Leppinen, N., MacDonald, H. R., Tobin, R., Rooman, R., Ward, L. M., Ahmet, A. H., & Dang, U. J. (2026) · Clinical Endocrinology · doi:10.1111/cen.70218
“Ueland et al. (2018) compared the Roche II cortisol assay to LCMS, another common method, and proposed a threshold for AI.”
Metadata
- Authors
- Ueland, G. Å., Methlie, P., Øksnes, M., Thordarson, H. B., Sagen, J., Kellmann, R., Mellgren, G., Ræder, M., Dahlqvist, P., Dahl, S. R., Thorsby, P. M., Løvås, K., & Husebye, E. S.
- Affiliations
- Haukeland University Hospital (NO)
- Bergen Spesialistsenter, Bergen, Norway
- Umeå University (SE)
- Oslo University Hospital (NO)
- Corresponding author
- Ueland, Grethe Å
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-02-14
- Volume
- 103
- Issue
- 4
- Pages
- 1696-1703
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2792804319
- Semantic Scholar
- 068a33dfa7e3affe53961d2cb79eb66f272506db
- Cited by
- 71
- References
- 27
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 6 · 2023: 9 · 2022: 14 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 3
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novo Nordisk Fonden (NNF14OC0011005)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- adrenal insufficiency, non-classical congenital adrenal hyperplasia, cortisol, 17-hydroxyprogesterone, reference values, cut-off values, LC-MS/MS, immunoassay comparison, false positives, adrenocortical function
- MeSH terms
- Adolescent, Adrenal Insufficiency, Adrenal Hyperplasia, Congenital, Adult, Aged, Aged, 80 and over, Chromatography, Liquid, Cosyntropin, Female, Humans, Hydrocortisone, Male, Middle Aged, Reference Values, 17-alpha-Hydroxyprogesterone, Tandem Mass Spectrometry, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.